Pikeville Medical Center is a 340-bed medical facility located in Pikeville, Kentucky.

There are 340 beds in Pikeville Medical Center.

During the past decade, Pikeville Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pikeville Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Gynecologic Oncology Group" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "GOG Foundation" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pikeville Medical Center" #1 collaborator was "NRG Oncology" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Nor Consult" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Pikeville Medical Center" are "Cervical Adenocarcinoma" (2 trials), "Cervical Adenosquamous Carcinoma" (2 trials), "Endometrial Clear Cell Adenocarcinoma" (2 trials), "Endometrial Serous Adenocarcinoma" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Pikeville Medical Center" in a lesser frequency.

Most popular intervention types in "Pikeville Medical Center" are "Drug" (11 trials), "Other" (5 trials), "Biological" (4 trials), "Radiation" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Quality-of-Life Assessment" (5 trials), "Carboplatin" (4 trials), "Laboratory Biomarker Analysis" (4 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pikeville Medical Center" are 7 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Pikeville Medical Center". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Pikeville Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pikeville Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Pikeville Medical Center has several departments that took part in Clinical trials: "Kentucky Cancer Clinic" - 2 trials